Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00829816 · ClinicalTrials.gov registry record · Phase 1
Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
A Phase 1 study, sponsored by Medivation.
- Completed
- Registry status
- Phase 1
- Development phase
- 46
- Enrollment target
NCT00829816 is a Phase 1 study that has completed, run by Medivation. The registered enrollment target is 46 participants.
The verdict
NCT00829816, a Phase 1 study, has completed, sponsored by Medivation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and tolerability of dimebon given to Alzheimer's disease patients currently on a stable dose and regimen of memantine or memantine plus donepezil.
Interventions
- DRUG Placebo
- DRUG Dimebon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00829816
The ClinicalTrials.gov registry entry for NCT00829816 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medivation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00829816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00829816 about?
NCT00829816 is a clinical study titled "Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil". The purpose of this study is to evaluate the safety and tolerability of dimebon given to Alzheimer's disease patients currently on a stable dose and regimen of memantine or memantine plus donepezil.
What is the current status of trial NCT00829816?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 2008-12. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00829816?
The interventions under investigation include: Placebo (DRUG), Dimebon (DRUG).
Who is sponsoring clinical trial NCT00829816?
This trial is sponsored by Medivation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.